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Saccharomyces cerevisiae target of rapamycin (TOR) complex 2 (TORC2) is an essential regulator of plasma
membrane lipid and protein homeostasis. How TORC2 activity is modulated in response to changes in the status
of the cell envelope is unclear. Here we document that TORC2 subunit Avo2 is a direct target of Slt2, the mitogen-
activated protein kinase (MAPK) of the cell wall integrity pathway. Activation of Slt2 by overexpression of a
constitutively active allele of an upstream Slt2 activator (Pkc1) or by auxin-induced degradation of a negative Slt2
regulator (Sln1) caused hyperphosphorylation of Avo2 at its MAPK phosphoacceptor sites in a Slt2-dependent
manner and diminished TORC2-mediated phosphorylation of its major downstream effector, protein kinase Ypk1.
Deletion of Avo2 or expression of a phosphomimetic Avo2 allele rendered cells sensitive to two stresses (myriocin
treatment and elevated exogenous acetic acid) that the cell requires Ypk1 activation by TORC2 to survive. Thus,
Avo2 is necessary for optimal TORC2 activity, and Slt2-mediated phosphorylation of Avo2 down-regulates TORC2
signaling. Compared with wild-type Avo2, phosphomimetic Avo2 shows significant displacement from the plasma
membrane, suggesting that Slt2 inhibits TORC2 by promoting Avo2 dissociation. Our findings are the first dem-
onstration that TORC2 function is regulated by MAPK-mediated phosphorylation.
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Cellular homeostasis requires careful coordination ofmet-
abolic growth processes and adaptive stress responses.
Multiple signaling networks coordinate expansion at the
cell boundary with the accumulation of intracellular
mass and progression through the cell cycle and also play
critical roles in responding to environmental fluctuations
that compromise the integrity of the plasma membrane
(PM) and, in yeast, the cell wall (Levin 2011).
Like all eukaryotes, yeast contains two evolutionarily
conserved multicomponent protein kinase complexes
in which a TOR (target of rapamycin) polypeptide is the
catalytic subunit: TOR complex 1 (TORC1) and TORC2.
TORC1 and TORC2 are essential regulators of growth
and homeostasis but control different aspects of yeast
cell physiology (González andHall 2017; Tatebe and Shio-
zaki 2017). TORC2 itself localizes to the PM (Berchtold
andWalther 2009). TORC2 is thought tomonitor the con-
dition of the cell envelope (PM and cell wall) and control,
through downstream effectors, processes that maintain
the integrity and function of these vital barriers. The pri-
mary target of TORC2 is the AGC family protein kinase
Ypk1 (and its paralog, Ypk2) (Kamada et al. 2005; Roelants
et al. 2011; Berchtold et al. 2012; Niles et al. 2012).
TORC2 activates Ypk1 by phosphorylating its C-terminal
segment at multiple sites, two of which are highly con-
served (the so-called “turn” and “hydrophobic” motifs),
but all of which are required for maximal Ypk1 catalytic
activity and for Ypk1 stability (Leskoske et al. 2017).
Ypk1 in turn phosphorylates multiple substrates that
modulate PM lipid and protein composition (for review,
see Gaubitz et al. 2016; Roelants et al. 2017a). It also has
been reported (Nomura and Inoue 2015) that TORC2
phosphorylates C-terminal turn-like and hydrophobic-
like motifs in Pkc1, an AGC protein kinase that controls
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the cell wall integrity (CWI) pathway (Levin 2011); howev-
er, whether TORC2-mediated phosphorylation of Pkc1 af-
fects its localization, stability, or activity has not been
demonstrated.
Conditions that perturb the PM stimulate TORC2-me-
diated phosphorylation of Ypk1, including sphingolipid
depletion (Roelants et al. 2011), hypotonic stress (Berch-
told et al. 2012; Niles et al. 2012), heat shock (Sun et al.
2012), and elevated exogenous acetic acid (Guerreiro et
al. 2016), whereas hyperosmotic stress inhibits TORC2-
mediated phosphorylation ofYpk1 (Lee et al. 2012;Muir et
al. 2015). How TORC2 “senses” different stresses could,
in some cases, involve direct feedback control. For exam-
ple, sphingolipids seem to negatively regulate TORC2
because treatment of cells with a potent inhibitor (myrio-
cin/ISP-1) of L-serine:palmitoyl-CoA C-palmitoyltrans-
ferase, the enzyme that catalyzes the first committed
step in sphingolipid biosynthesis, causes up-regulation
of TORC2-dependent and Ypk1-mediated phosphoryla-
tion of proteins whose modification markedly stimulates
the rate of sphingolipid production (Roelants et al. 2011;
Muir et al. 2014).
In addition, however, other pathways that sense PM or
cell wall stress may exert some of their effects via reg-
ulation of TORC2 function. In this regard, two mitogen-
activated protein kinase (MAPK) pathways in yeast sense
and respond to stresses that challenge the cell envelope:
the high-osmolarity glycerol (HOG) pathway, whose ter-
minal MAPK is Hog1 (Saito and Posas 2012), and the
CWI pathway,whose terminalMAPK is Slt2/Mpk1 (Levin
2011). Hog1 activation, which can occur via a branch de-
pendent on PM sensor Sln1 or a branch dependent on
PM sensor Sho1, is required for cell survival under hyper-
tonic conditions (Saito and Posas 2012) but can also be
evoked by other environmental insults, including both
heat shock (Winkler et al. 2002) and cold shock (Panadero
et al. 2006), citric acid stress (Lawrence et al. 2004), hypox-
ia (Hickman et al. 2011), glucose starvation (Vallejo and
Mayinger 2015), and, most notably from the perspective
of this study, sphingolipid depletion (Tanigawa et al.
2012). Slt2 activation, which is initiated via stretch sen-
sors anchored in both the PM and the cell wall (Wsc1,
Mid2, and others) (Levin 2011), is required for cell survival
under hypotonic conditions (Davenport et al. 1995) but
can also be elicited by heat shock (Kamada et al. 1995)
and agents that directly damage the cell wall, such as
zymolyase, Calcofluor White, or Congo Red (de Nobel et
al. 2000; García et al. 2004; Rodríguez-Peña et al. 2013).
When activated, the stretch sensors recruit to the PM
and activate Rom2 and/or Tus1—guanine nucleotide ex-
change factors (GEFs) for the Rho1 GTPase. GTP-bound
Rho1 then binds to and activates Pkc1, which in turn ac-
tivates the CWIMAPK cascade (Levin 2011). Rho1 and its
GEFs also localize at sites of polarized growth to promote
cell wall glucan synthesis, actin cytoskeleton organiza-
tion, and targeting of secretory vesicles to growth sites
(Perez and Rincón 2010).
Significant cross-talk exists between the HOG and CWI
pathways (Hahn and Thiele 2002; García-Rodríguez et al.
2005; Fuchs and Mylonakis 2009; García et al. 2009) and
between these MAPK pathways and TORC2 function.
For example, down-regulation of TORC2–Ypk1 signaling
and activation of Hog1 act in concert to maintain cell vi-
ability during hyperosmotic stress (Muir et al. 2015). In ad-
dition, one of the first functions reported for Tor2 (the
TOR subunit unique to TORC2) was proper polarization
of the actin cytoskeleton (Schmidt et al. 1996), linking
Tor2 to Rho1 and the CWI pathway. Indeed, various
means to stimulate CWI pathway output rescue the invi-
ability and actin polarization defects associated with loss
of TORC2 or Ypk1 function (Helliwell et al. 1998; Roe-
lants et al. 2002). In addition, TORC2–Ypk1 signaling,
through its role in regulating lipid composition and orga-
nization, influences PM localization of Rho1 and Rom2
(Niles and Powers 2014; Hatakeyama et al. 2017).
In this study, we sought to establish whether the CWI
MAPK pathway directly modulates TORC2–Ypk1 signal-
ing, given the cumulative evidence for the interconnec-
tions between them. As documented here, we found
that activation of the CWI pathway MAPK results in di-
rect Slt2-mediated phosphorylation of TORC2 subunits
and that these modifications down-regulate TORC2–
Ypk1 signaling. By pinpointing the molecular basis of
this negative regulation, our results provide new mecha-
nistic insight into how TORC2 senses cell envelope
stress.
Results
TORC2 subunits are targets of the Slt2 MAPK
TORC2 is a 1.4-MDa dimeric complex in which each pro-
tomer is a hetero-oligomer comprising Tor2, Lst8, Avo1,
Avo2, Avo3, and either Bit2 or Bit61 (Wullschleger et al.
2005; Karuppasamy et al. 2017). Phosphoproteomic analy-
ses (for compilations, see the Saccharomyces Genome
Database, https://www.yeastgenome.org) have detected
in vivo phosphorylation of -SP- and -TP- sites in four of
the six TORC2 subunits (Fig. 1A). Most strikingly, nine
such sites are present in Avo2, and four confirmed sites
cluster at its C-terminal end; 11 sites are present in
Avo3, and five confirmed sites cluster at its N-terminal
end (Fig. 1A). Both Hog1 and Slt2 phosphorylate only
-SP- or -TP- motifs (Mok et al. 2010), just like the pro-
line-directed Ser- or Thr-specific MAPKs in other eukary-
otes (Roux and Blenis 2004).
To determine whether any -SP- or -TP- sites in TORC2
subunits are direct targets of the Slt2 MAPK, we focused
initially on Avo2. As expected for a phosphoprotein,
Avo2 exists, even under basal conditions, in a series of
isoforms of distinct mobility, as resolved by Phos-tag
SDS-PAGE (Fig. 1B), a technique in which the degree of
retardation of a protein reflects the extent of its phosphor-
ylation (Kinoshita et al. 2009). A convenientmethod to ac-
tivate Slt2 in the absence of an external stimulus is
overexpression of a constitutively active Pkc1 allele,
Pkc1(R398A R405A K406A) (referred to here as PKC1∗)
(Martín et al. 2000), which is hyperactive because residues
critical for the inhibitory function of its pseudosubstrate
sequence have been mutated. After induction of PKC1∗
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expression, Avo2 became hyperphosphorylated, and the
increase in Avo2 phosphorylation coincided with the ki-
netics of appearanceof activeSlt2 (Fig. 1B).Overexpression
of a catalytically inactive (“kinase-dead” [KD]) derivative,
Pkc1∗(D949A), to the same level as Pkc1∗ (Fig. 1C) did not
activate Slt2 or alter Avo2 phosphorylation (Fig. 1B).
In addition to robust Slt2 activation, we noted that over-
expression of Pkc1∗ also evokedHog1 activation, in agree-
ment with other observations demonstrating cross-talk
between these two MAPK pathways (Hahn and Thiele
2002; García-Rodríguez et al. 2005; Fuchs and Mylonakis
2009; García et al. 2009). Therefore, to distinguish which
MAPKwas primarily responsible for the Avo2 hyperphos-
phorylation induced by Pkc1∗ overexpression, we repeat-
ed these experiments in both slt2Δ and hog1Δ mutants.
We found that the Pkc1∗-induced mobility shift was
markedly reduced in slt2Δ cells but not in hog1Δ cells
(Fig. 1D). Moreover, to confirm that the Pkc1∗-induced
Slt2-mediated modifications were occurring on the
-SP- and -TP- sites, the same experiments were repeated
with an Avo2 allele (Avo29A) in which all nine sites
were mutated to Ala. Indeed, absence of these sites pre-
vented Pkc1∗-induced hyperphosphorylation of Avo2
(Fig. 1D). Although Slt2 appears to be the majorMAPK re-
sponsible for Pkc1∗-induced hyperphosphorylation of
Avo2, these modifications were not completely abrogated
in slt2Δ cells and were modestly reduced in hog1Δ cells
compared with wild-type cells, suggesting that Hog1
makes a minor contribution to Pkc1∗-induced hyperphos-
phorylation of Avo2.
In further support of the capacity of Slt2 to modify
Avo2, wild-type Slt2 immuno-enriched from cells overex-
pressing Pkc1∗—but not a catalytically deficient deriva-
tive, Slt2(K54R), purified in the same manner—robustly
phosphorylated recombinant wild-type Avo2 in vitro,
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Figure 1. MAPK Slt2 phosphorylates TORC2 subunits Avo2
and Avo3. (A) The primary structure of each indicated TORC2
subunit is depicted schematically, with domains labeled as in
Gaubitz et al. (2016). (Black asterisk) An -SP- or -TP- site; (red
asterisk) an -SP- and -TP- detectably phosphorylated in vivo in
various phosphoproteomic analyses, as cataloged in the Sac-
charomyces Genome Database (http://www.yeastgenome.org).
(B) Wild-type cells (JTY5336) carrying both a CEN plasmid ex-
pressing Avo2-3xFlag (pKL1) from theAVO2 promoter and amul-
ticopy (2 µm DNA) vector expressing either Pkc1∗ (pJT5660) or
catalytically inactive Pkc1∗KD (pJEN12) from theGAL1 promot-
er were cultured to mid-exponential phase in selective minimal
medium containing 2% raffinose and 0.2% sucrose. Expression
of Pkc1∗ or Pkc1∗KDwas induced by addition of galactose (2% fi-
nal concentration). Cell samples were removed at the indicated
times and lysed, the proteins in the resulting extracts were re-
solved by Phos-tag SDS-PAGE, and the indicated proteins were
analyzed by immunoblotting with the appropriate antibodies,
all as described in theMaterials andMethods. Pgk1 was the load-
ing control. (C ) As in B except the cells carried plasmids express-
ing either Pkc1∗-myc (pAEA376) or Pkc1∗KD-myc (pJEN13), and
the extracts were resolved by standard SDS-PAGE prior to immu-
noblotting. (D) Wild-type cells (JTY5336) or otherwise isogenic
slt2Δ (YFR549) or hog1Δ (YFR538-A) derivatives carrying plas-
mids expressing either Avo2-3xFlag (pKL1) or Avo29A-3xFlag
(pKL2), as indicated, as well as either empty vector (yEPlac112)
or the same vector expressing Pkc1∗ from the GAL1 promoter
(pJT5660), as shown, were grown to mid-exponential phase in
selective minimal medium containing 2% raffinose and 0.2%
sucrose. After addition of galactose (2% final concentration),
the cells were cultured for 3 h, harvested, and lysed, and the indi-
cated proteins were analyzed as in B. (E) Activated wild-type Slt2
(pKL63) and kinase-dead (KD) Slt2 (pKL64) were purified from
Saccharomyces cerevisiae as described in the Materials and
Methods and incubated with [γ-32P]ATP and either GST-Avo2WT
(pKL16) or GST-Avo29A (pKL17) purified from Escherichia coli as
described in the Materials and Methods. Reaction products were
resolved by SDS-PAGE and analyzed by Coomassie blue staining
(left) and autoradiography (right). (F ) As in E, except the substrates
were purified recombinant GST-Avo3(1-100) (pKL81) or GST-
Avo3(1-100)6A (pKL82). (G) A strain (YFR617) expressing Avo3-
3xFlag and carrying a plasmid expressing either Pkc1∗KD
(pJEN12) or Pkc1∗ (pJT5660) from theGAL1 promoterwas grown,
induced with galactose for 2.5 h, lysed, and analyzed by Phos-tag
SDS-PAGE as in B.
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and this incorporation was eliminated in an Avo29A mu-
tant (Fig. 1E).
Likewise, Avo3(1–100), an N-terminal fragment con-
taining six of the 11 -SP- and -TP- sites in Avo3 (five of
which have been detected as phosphorylated in vivo),
was robustly phosphorylated in vitro by wild-type Slt2
but not by the catalytically deficient Slt2 mutant, and in-
corporation was markedly reduced by mutation of the six
sites to Ala (Fig. 1F). Moreover, as judged by its mobility
shift, intact Avo3-3xFlag was phosphorylated in vivo
upon overexpression of Pkc1∗ but not upon overexpres-
sion of Pkc1∗KD (Fig. 1G). Collectively, these results
show that at least two core subunits of TORC2 are phys-
iologically relevant substrates of the Slt2 MAPK.
MAPK phosphorylation of Avo2 impairs TORC2 activity
Unlike Avo3 (1430 residues), which is essential for
TORC2 function because it has an important structural
role (Wullschleger et al. 2005; Karuppasamy et al. 2017),
Avo2 is a relatively small (426 residues) peripherally locat-
ed nonessential subunit of TORC2, with the highest over-
all density of -SP- and -TP- sites (Fig. 1A), suggesting that
its Slt2-mediated phosphorylation might have a readily
detectable regulatory role. To examine this possibility,
in addition to wild-type Avo2 and the MAPK site-defi-
cient Avo29A mutant, we also generated a phosphomi-
metic allele, Avo29E. First, we found that all three
proteins were expressed at comparable steady-state levels
(Fig. 2A); thus, the absence or presence of MAPK phos-
phorylation does not affect Avo2 stability. Strikingly,
however, even though Avo2 is nonessential for cell viabil-
ity under nonstress conditions, we found that Avo2 is
essential for cell survival during myriocin-induced sphin-
golipid depletion (Fig. 2B, top row), a condition in which
cells require full TORC2-mediated activation of Ypk1 to
survive (Roelants et al. 2011; Leskoske et al. 2017). Fur-
thermore, compared with cells expressing wild-type
Avo2 or Avo29A, cells expressing Avo29E were much
more sensitive to the growth inhibitory effect of myriocin
(Fig. 2B), suggesting that, like avo2Δ cells, they are defi-
cient in TORC2-dependent Ypk1 activation. In direct sup-
port of that conclusion, the myriocin sensitivity of both
the avo2Δ mutant and Avo29E-expressing cells was res-
cued by coexpression of a Ypk1 allele, Ypk1(D242A),
that is fully active in the absence of TORC2 phosphoryla-
tion (Fig. 2C; Kamada et al. 2005; Roelants et al. 2011;
Leskoske et al. 2017). These findings indicate that Avo2
is required for optimal TORC2 function and that phos-
phorylation interferes with Avo2 function, resulting in
down-regulation of TORC2 activity.
These conclusions were confirmed by monitoring
TORC2 activity in vivo. We documented previously
that TORC2 phosphorylates Ypk1 at multiple sites that
lie within 40 residues of its C terminus and that full phos-
phorylation of these sites is necessary for both maximal
Ypk1 activity and Ypk1 stability (Leskoske et al. 2017).
Therefore, to assess TORC2 activity in vivo, we examined
phosphorylation of Ypk1 at four of its C-terminal TORC2-
dependent phosphorylation sites using Phos-tag SDS-
PAGE. Treatment with myriocin, a condition that
activates TORC2 activity in wild-type cells, failed to
stimulate TORC2 phosphorylation of Ypk1 in Avo29E-
expressing cells (Fig. 2D). As presented further below,
Avo2 has also been found in association with PM
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Figure 2. Phosphorylation of Avo2 at its MAPK sites impairs
TORC2 activity. (A) Otherwise isogenic strains JTY7318
(avo2Δ), yKL32 (Avo2WT-3xFlag), yKL34 (Avo29E-3xFlag), and
yKL33 (Avo29A-3xFlag) were grown to mid-exponential phase in
rich medium, harvested, and lysed, and the resulting extracts
were resolved by SDS-PAGE and analyzed by immunoblotting,
as described in the Materials and Methods. Pgk1 was the loading
control. (B) Overnight cultures of the strains inAwere adjusted to
A600 nm =0.1, spotted undiluted and in a series of fivefold serial di-
lutions on YPD plates either lacking or containing 0.8 µMmyrio-
cin, incubated for 3 d at 30°C, and then imaged. (C ) Strains
JTY7318 (avo2Δ), yKL32 (Avo2WT-3xFlag), or yKL34 (Avo29E-
3xFlag) expressing either empty vector (pRS315) or Ypk1D242A-
myc from the same vector (pFR234) were adjusted to A600 nm=
0.1, spotted as in B but on SCD-L-T plates lacking or containing
myriocin at the indicated concentrations, and imaged after incu-
bation for 3 d at 30°C. (D) Wild-type (BY4742), Avo29A (YFR528),
or Avo29E (yKL31) strains expressing Ypk15A-myc from its native
promoter on aCEN plasmid (pFR246) were cultured to mid-expo-
nential phase in selectiveminimalmediumand then treatedwith
vehicle (methanol) or 1.25 µMmyriocin for 2 h. After harvesting,
whole-cell lysates were prepared, resolved by SDS-PAGE, and
analyzed as described in the Materials and Methods. A repre-
sentative of three independent experiments is shown. (E) As in
D, except strains BY4742 and Avo29E Pil13D (YFR641) were
used. (F ) Overnight cultures of the strains in A were adjusted to
A600 nm=0.1, spotted undiluted and in a series of 10-fold serial di-
lutions on SCD plates either lacking or containing acetic acid at
the indicated concentrations, and imaged after incubation for 3
d at 30°C.
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structures called eisosomes (Douglas and Konopka 2014),
and Pil1, amajor eisosome component, has been shown to
be another target of Slt2 (Mascaraque et al. 2013). Hence,
we also examined Ypk1 phosphorylation in cells express-
ing both Avo29E and Pil13D and again found that, unlike in
wild type or cells expressing Pil13D alone (Supplemental
Fig. S1), myriocin treatment failed to stimulate TORC2
phosphorylation of Ypk1 in the cells expressing both
Avo29E and Pil13D (Fig. 2E). These additional observations
verify that it is phosphorylation of Avo2 that makes a ma-
jor contribution to interfering with TORC2 function.
Another stress that cells require TORC2-mediated
Ypk1 activation to survive is exposure to elevated exoge-
nous acetic acid (Guerreiro et al. 2016). As with myriocin
treatment, avo2Δ cells were markedly more sensitive to
this stress than wild-type cells, and cells expressing
Avo29E were detectably more sensitive than cells express-
ing either wild-type Avo2 or especially Avo29A (Fig. 2F).
These results again show that Avo2 is required for full
TORC2 activity and that MAPK phosphorylation of
Avo2 impairs TORC2 function.
Slt2 MAPK action down-regulates TORC2 function
As assessed by Phos-tag SDS-PAGE, after induction of
Pkc1∗KD, there was no change in the pattern of TORC2-
dependent Ypk1 isoforms over the course of 2.5 h, where-
as after induction of Pkc1∗, there was a decrease in the
slowest mobility (most highly phosphorylated) isoforms,
concomitant with the appearance of activated Slt2
(Fig. 3A), as well as a marked reduction of total Ypk1 pro-
tein (Fig. 3A,B), indicating that activation of the CWI
pathway prevented TORC2-mediated phosphorylation
of Ypk1. The observed Pkc1∗-induced down-regulation
of TORC2-mediated Ypk1 phosphorylation and loss of
Ypk1 protein was largely prevented in a slt2Δ mutant
but not in hog1Δ or kss1Δ single mutants or a hog1Δ
kss1Δ double mutant (Fig. 3C). We examined a kss1Δmu-
tation alone or in combination with other MAPK-null
mutations because we noted that overexpression of
Pkc1∗ sometimes mildly increased the amount of dually
phosphorylated (activated) Kss1 MAPK (Fig. 1D). Howev-
er, compared with the slt2Δ cells, the levels of Ypk1
BA
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Figure 3. Activation of MAPK Slt2 down-regulates
TORC2-mediated Ypk1 phosphorylation. (A) Strain
JTY5336 expressing Ypk15A-myc from its native pro-
moter on a CEN plasmid (pFR246) and expressing
from the GAL1 promoter on plasmids either
Pkc1∗KD (pJEN12) or Pkc1∗ (pJT5660), as indicated,
were cultured to mid-exponential phase in selective
minimal medium containing 2% raffinose and 0.2%
sucrose and induced by addition of galactose (2% fi-
nal concentration), and samples taken at the indicat-
ed time points were lysed and analyzed by Phos-tag
SDS-PAGE and immunoblotting, as described in the
Materials andMethods. Pgk1was the loading control.
(B) Strain JTY5336 expressing Ypk15A-myc from its
native promoter on a CEN plasmid (pFR246) and car-
rying either empty vector (−) (yEPlac112) or express-
ing Pkc1∗ (+) from the GAL1 promoter on the same
vector were grown as in A and harvested 2 h after ga-
lactose induction, and the relative level of Ypk1 pro-
tein was determined and normalized to the Pgk1
loading control (ratiowas set at 100 for the empty vec-
tor control) by SDS-PAGE and immunoblotting. A
representative image is shown for an experiment
that was repeated three independent times. (C )
Strains JTY5336 (HOG1+KSS1+SLT2+), YFR549
(slt2Δ), YFR538-A (hog1Δ), YFR560 (kss1Δ), YFR559
(slt2Δ hog1Δ), YFR567 (slt2Δ kss1Δ), and YFR564
(hog1Δ kss1Δ) expressing Ypk15A-myc from its native
promoter on a CEN plasmid (pFR246) and coexpress-
ing Pkc1∗ from the GAL1 promoter on a plasmid
(pJT5660) were cultured to mid-exponential phase
in selective minimal medium containing 2% raffi-
nose and 0.2% sucrose and induced by addition of
galactose (2% final concentration), and, after 2.5 h,
samples were lysed and analyzed as in A. Pgk1 was
the loading control. (Red dots) TORC2-dependent isoforms of Ypk1 that persist. (D) As in C, except the cells coexpressed Pkc1∗KD from
theGAL1 promoter on the plasmid (pJEN12). (E) Wild-type (BY4741) cells expressing Ypk15A-myc from its native promoter on aCEN plas-
mid (pFR246) were cultured to mid-exponential phase in selective minimal medium and then treated with increasing amounts of Congo
Red (0, 10, 20, or 40 µg/mL final concentration) for 2 h. After harvesting, whole-cell lysates were prepared, resolved by SDS-PAGE, and an-
alyzed as described in theMaterials andMethods. (F ) Same as in E, except that wild-type (JTY5336) and slt2Δ (YFR549) strains were used,
and, when added, Congo Red was added at 20 µg/mL final concentration.
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phosphorylation or Ypk1 protein were not further en-
hanced in hog1Δ slt2Δ or kss1Δ slt2Δ double mutants
(Fig. 3C). Most revealingly, in every case where Slt2 is ab-
sent, two of the most prominent and highly TORC2 phos-
phorylated Ypk1 isoforms persisted (Fig. 3C, red dots).
Thus, Slt2 is the MAPK primarily responsible for inhibit-
ing TORC2-mediated Ypk1 phosphorylation.
It has been reported that Pkc1 is a substrate of TORC2
(Nomura and Inoue 2015); hence, it was possible that over-
expression of even Pkc1∗KD might titrate away a suffi-
cient amount of TORC2 to interfere with its efficient
phosphorylation of Ypk1. However, this was not the
case because, in either wild-type cells or all of these
same mutants, induction of Pkc1∗KD had little or no ef-
fect on the pattern of the Ypk1 isoforms (Fig. 3D). Further-
more, treatment of cells expressing normal Pkc1 and Slt2
at their endogenous levels with the cell wall-perturbing
dye Congo Red, a physiological condition that has been
demonstrated to elicit Pkc1-dependent Slt2 activation
(de Nobel et al. 2000), resulted in down-regulation of
TORC2 function (Fig. 3E), and the down-regulation was
dependent on Slt2 (Fig. 3F).
TORC2 is down-regulated during sustained Sln1
inactivation
Sln1 is a histidine kinase similar to those in bacterial
two-component signaling systems, and its inactivation,
as occurs during hyperosmotic shock, leads to activation
of the Hog1 MAPK (Saito and Posas 2012). In a global
screen of the Saccharomyces cerevisiaekinome, we found
that, like a tor2ts mutant (Leskoske et al. 2017), when a
sln1ts mutant was shifted to the restrictive temperature,
there was a dramatic loss of TORC2-dependent Ypk1
phosphorylation (Supplemental Fig. S2A) that was accom-
panied by hyperphosphorylation of Avo2 (Supplemental
Fig. S2B), indicating that, like activation of the CWI
MAPK pathway, activation of the HOG MAPK pathway
down-regulates TORC2 function and does so via a similar
mechanism.
To confirm this conclusion and inactivate Sln1 inde-
pendently of any external temperature or hypertonic
stress, we constructed a strain expressing the plant
F-box protein Tir1 and an allele of Sln1 taggedwith amod-
ified auxin-inducible degron (AID∗), which should cause
Sln1 to be degraded in an SCF-mediatedmanner upon aux-
in addition (Morawska and Ulrich 2013). Adding a syn-
thetic auxin (1-naphthaleneacetic acid [1-NAA]) to cells
expressing untagged Sln1 had no effect on the level of
Sln1 or on the Ypk1 isoforms present and did not activate
either Hog1 or Slt2 (Fig. 4A, left). The same treatment of
cells expressing AID∗-tagged Sln1 resulted in its rapid deg-
radation, as expected, as well as the loss of the Ypk1 iso-
forms, concomitant with the activation of both Hog1
and Slt2 (Fig. 4A, right), in agreement with prior work
showing that Hog1 activation leads to Slt2 activation
(García-Rodríguez et al. 2005). Thus, we again found
that MAPK activation coincided with down-regulation
of TORC2 activity, as judged by the dramatic drop in
Ypk1 C-terminal phosphorylation and protein level.
Consistent with the cross-talk by which activation of
Hog1 leads to activation of Slt2 (García-Rodríguez et al.
2005), the drastic reduction in Ypk1C-terminal phosphor-
ylation and protein level caused by Sln1 degradation was
ameliorated in either a hog1Δ mutant or a slt2Δ mutant
andwas not further enhanced in a hog1Δ slt2Δ doublemu-
tant (Fig. 4B).Moreover, similar towhatwe observed upon
Pkc1∗-induced CWI pathway activation, activation of the
HOG pathway by Sln1 degradation markedly stimulated
phosphorylation of Avo2, as judged by the shift to a spec-
trum of slower mobility isoforms in the Phos-tag gel
(Fig. 4C, left two lanes), and no such shift was observed
C
B
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Figure 4. TORC2 function is down-regulated after Sln1 degrada-
tion. (A) Strains yKL15 (Sln1-6xHA TIR1) or yKL18 (Sln1-AID∗-
6xHA TIR1) expressing Ypk15A-myc from its native promoter
on aCEN plasmid (pFR246)were grown tomid-exponential phase
in phosphate-buffered selective minimal medium (pH 6.2) and
treated with 1 mM 1-NAA (final concentration), and samples
were withdrawn at the indicated times, lysed, subjected to
Phos-tag SDS-PAGE to resolveYpk1 phosphorylation and to stan-
dard SDS-PAGE to resolve the other proteins, and analyzed by im-
munoblotting as described in the Materials and Methods.
(B) Strains yKL18 (Sln1-AID∗-6xHA TIR1 HOG1+ SLT2+), yKL20
(Sln1-AID∗ TIR1 hog1Δ), yKL16 (Sln1-AID∗ TIR1 slt2Δ), and
yKL22 (Sln1-AID∗ TIR1 hog1Δ slt2Δ), all expressing Ypk15A-
myc from its native promoter on a CEN plasmid (pFR246), were
grown as in A, treated with either solvent alone (DMSO) or 1
mM 1-NAA (final concentration) in the same volume of solvent
for 90 min, harvested, lysed, and analyzed as in A. (C ) The same
strains as in B, except expressing either Avo2WT-3xFlag (pKL1)
or Avo29A-3xFlag (pKL2), as indicated, were grown and treated
as in B, except that the incubation with 1-NAA was for 2 h, and
samples of each culture were analyzed as in A, with Avo2 phos-
phorylation resolved by Phos-tag SDS-PAGE, and the other pro-
teins resolved by standard SDS-PAGE.
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for the Avo29A mutant, indicating that these modifica-
tions were occurring on its -SP- and -TP- sites (Fig. 4C,
right two lanes). Furthermore, there was no change in
the pattern of Avo2 isoforms upon Sln1 degradation in
cells lacking either Hog1 or Slt2 (or both) (Fig. 4C, middle
lanes), indicating that Avo2 phosphorylation was MAPK-
dependent. Importantly, activation of Hog1 alone (upon
degradation of Sln1 in slt2Δ cells) was not sufficient to
down-regulate TORC2-mediated Ypk1 phosphorylation
(Fig. 4B) or stimulate Avo2 phosphorylation (Fig. 4C), indi-
cating that Slt2 is the MAPK responsible for these effects
and that, in this case, the primary role of activated Hog1 is
to stimulate production of activated Slt2.
Interestingly, we documented previously that when the
HOG pathway is activated by exposure of cells to 1M sor-
bitol, a cell-impermeable osmolyte that robustly but tran-
siently activates Hog1 (Saito and Posas 2012), there is
rapid and transient collapse of the TORC2-dependent
Ypk1 isoforms, but that response still occurs even in
hog1Δ cells (Lee et al. 2012; Muir et al. 2015). Although
treatmentwith 1M sorbitol activatesHog1, it does not ac-
tivate Slt2, and the collapse of the TORC2-dependent
Ypk1 isoforms still occurs in cells lacking either Slt2 or
Hog1 (or both) (Supplemental Fig. S3). Thus, in contrast
to the Slt2-dependent down-regulation of TORC2-mediat-
ed Ypk1 phosphorylation that occurs upon prolonged in-
activation of Sln1, the loss of the TORC2-dependent
Ypk1 isoforms caused by exposure to 1 M sorbitol occurs
in aMAPK-independentmanner. Possibly, the hypertonic
shock caused by 1 M sorbitol activates an as yet to be
identified phosphatase. In any event, both acute and
chronic stimulation of the HOG pathway leads to down-
regulation of TORC2–Ypk1 signaling, albeit by different
mechanisms.
MAPK phosphorylation of Avo2 alters its subcellular
localization
Studies of various integral and peripheral PM proteins
in yeast have shown that different components often re-
side in discrete microdomains (Spira et al. 2012). Many
permeases, such as the arginine transporter Can1, colocal-
ize in a membrane compartment called the “MCC”
that is congruent with eisosomes (Strádalová et al.
2009), protein-coated PM invaginations whose major
constituents include Pil1, an F-BAR (FCH/bin-amphiphy-
sin-rvs) domain-containing protein (Karotki et al. 2011).
Initially, it was reported that all of the components of
TORC2, including Avo2, reside in a PM microdomain
dubbed the “MCT” that is distinct from eisosomes (Berch-
told and Walther 2009). However, subsequent work dem-
onstrated that Avo2 partitions between TORC2 and
eisosomes (Bartlett et al. 2015). For these reasons, and hav-
ing established that MAPK phosphorylation does not af-
fect Avo2 stability (Figs. 2A, 5C), to explain how MAPK
phosphorylation of Avo2 contributes to down-modulation
of TORC2 activity, we examined whether MAPK phos-
phorylation of Avo2 affected its subcellular localization.
Toward that end, we expressed either Avo2, Avo29A, or
Avo29E (each tagged at its C terminus with mNeon Green
[mNG]) (Shaner et al. 2013) from its endogenous locus on
chromosome XIII in cells coexpressing the eisosome
marker Pil1 (tagged at its C terminus with red fluorescent
protein [RFP]) (Fradkov et al. 2000) from its endogenous lo-
cus on chromosome VII. We document (1) that Avo2-
mNG is fully functional (Supplemental Fig. S4) and (2)
that both Avo2-mNG and Pil1-RFP displayed a punctate
distribution at the PM and that these puncta were often,
but not always, congruent (Fig. 5A, left), as we resolved
and quantified using CellProfiler and appropriatemasking
(Supplemental Fig. S5). The same was observed for
Avo29A-mNG and Pil1-RFP (Fig. 5A, middle). However,
there were significant differences found in the cells ex-
pressing Avo29E-mNG and Pil1-RFP. Generally, the
Avo29E-containing puncta were smaller and less promi-
nent (Fig. 5A, right), and their overall mean pixel intensity
was significantly lower than in cells expressing Avo2 or
Avo29A (Fig. 5B) despite the fact that the total amount of
Avo2, Avo29A, and Avo29E in each of these cells was
very similar (Fig. 5C), and the intensity of the Pil1-RFP
foci remained essentially unchanged (Fig. 5A,B). More-
over, the decrease in the intensity of the Avo29E-contain-
ing PM puncta was the same regardless of whether the
Avo29E colocalized with Pil1 (Fig. 5D) or was located at
distinct PM sites, presumably with TORC2 (Fig. 5E). Tak-
en together, these findings suggest that MAPK phosphor-
ylation promotes dissociation of Avo2 from either of its
two PM sites: eisosomes and TORC2.
To confirm that conclusion for TORC2 specifically by
an independent biochemical approach, we immuno-iso-
lated TORC2 (in which the Avo3 subunit carried a 3xFlag
epitope tag) from the cells expressing Avo2, Avo29A, or
Avo29E and analyzed the amount of Avo2 present in these
complexes. In the immunoprecipitates obtained using
anti-Flag antibodies, equivalent amounts of both Avo3-
3xFlag and the Tor2 catalytic subunit were found regard-
less of whether the cells expressed Avo2, Avo29A, or
Avo29E (Fig. 5F). Likewise, in cells expressing Tor2-
mNG and Avo2, Avo29A, or Avo29E, there was little or
no effect on the amount of Tor2 present in PM-associated
TORC2 (Supplemental Fig. S6). However, quantification
of the immunoprecipitates showed that, compared with
the amount of Avo2 or Avo29A bound to TORC2, the
amount of Avo29E was always reduced by 30%–40%.
Thus, in agreement with the observations made by fluo-
rescence imaging, these results suggest that MAPK phos-
phorylation of Avo2 promotes its dissociation from
TORC2.
Discussion
It has been unclear whether TORC2 adjusts its activity by
serving itself as a direct sensor of perturbations to the cell
envelope or responding to inputs fromother stress-sensing
pathways (or both). We demonstrated here, for the first
time, that Slt2/Mpk1 (mammalian ortholog ERK5/
MAPK7) (Truman et al. 2006), the MAPK of the CWI
pathway, phosphorylates two subunits of TORC2 (Avo2
and Avo3) and, as a result, down-regulates TORC2
Slt2 phosphorylates and down-regulates TORC2
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phosphorylation of its primary downstream effector, AGC
family kinase Ypk1 (mammalian ortholog SGK1) (Casa-
mayor et al. 1999). We also found that modification of
Avo2 was sufficient to explain Slt2-mediated inhibition
of TORC2, but it is possible that Slt2 phosphorylation of
Avo3 also contributes to TORC2 down-modulation. Like-
wise, all of the other subunits of TORC2 contain potential
MAPK phosphorylation sites; however, unlike for Avo2
and Avo3, phosphorylation at very few of these other can-
didate sites has been detected in global phosphoproteomic
studies.
In any event, the control circuit that we discovered
makes physiological sense because under conditions
that interfere with cell wall synthesis or damaged cell
A B
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Figure 5. Phosphorylation at its MAPK sites displaces Avo2 from the PM. (A) Strains yAEA348 (Avo2WT-mNG-3xHA Pil1-RFP),
yAEA349 (Avo29A-mNG-3xHA Pil1-RFP), and yAEA350 (Avo29E-mNG-3xHA Pil1-RFP) were grown tomid-exponential phase and exam-
ined by fluorescence microscopy as described in theMaterials andMethods and processed using CellProfiler (as in Supplemental Fig. S3).
(B) Mean values of the relative pixel intensities of the Pil1-RFP and Avo2-mNG foci in images, as inA, were measured using CellProfiler,
and those obtained for strain yAEA348 (Avo2WT-mNG-3xHA Pil1-RFP) were set to 100%, to which all of the other values were normal-
ized. Error bars represent 95% confidence intervals. (∗∗) P <0.0001. (C ) The same cells as in Awere resolved by standard SDS-PAGE and
analyzed by immunoblotting. A representative experiment is shown. Values below the lanes represent the relative Avo2 to Pgk1 ratio
(average of three independent experiments with SEM). (D) The mean pixel intensity of the Avo2-mNG foci that colocalized with Pil1-
RFP was measured using CellProfiler as in B. (∗∗) P<0.0001. (E) The mean pixel intensity of the Avo2-mNG foci that did not colocalize
with Pil1-RFP was measured using CellProfiler as in B. (∗∗) P< 0.0001. (F ) Strains BY4741, YFR589 (Avo2-mKate Tor2-mNG-3xHA),
YFR624 (Avo2-mKate Avo3-3xFlag Tor2-mNG-3xHA), YFR626 (Avo29A-mKate Avo3-3xFlag Tor2-mNG-3xHA), and YFR628 (Avo29E-
mKate Avo3-3xFlag Tor2-mNG-3xHA) were propagated in YPD, harvested, and lysed, and equal amounts of the resulting extracts
were immunoprecipitated with anti-Flag antibody. Proteins in the input extracts and in the immunoprecipitates were resolved by
SDS-PAGE and analyzed by immunoblotting. A representative experiment is shown. Values below the right lanes represent the relative
Avo2 to Tor2 ratio (average of three independent experiments with SEM), with the value obtained for strain YFR624 (Avo2-mKate Avo3-
3xFlag Tor2-mNG-3xHA) set as 1.00. (G) Model showing that under conditions that damage cell wall structure, activation of the CWI
pathway exerts feedback that will negatively regulate the growth-promoting functions of TORC2.
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wall structure, activation of the CWI pathway will exert
feedback that will negatively regulate the growth-promot-
ing functions of TORC2 (Fig. 5G). For yeast cell growth,
enlargement of the cell wall needs to be tightly coupled
to both an increase in cell mass and expansion of the
PM. TORC2–Ypk1 signaling controls the processes that
maintain adequate PM levels of all of the lipid classes
(sphingolipids, glycerolipids, and sterols) needed to sus-
tain growth and viability (Roelants et al. 2017a, 2018).
Thus, down-regulation of TORC2 activity upon CWI
pathway activation provides a mechanism by which the
status of the cell wall can be sensed by TORC2 and there-
by the rates of the reactions necessary for PMhomeostasis
can be adjusted accordingly.
The need for regulatory circuitry in which the state of
the cell wall can feed in and influence TORC2 function
perhaps explains why a recognizable Avo2 homolog is pre-
sent throughout the vast majority of the fungal clade—
from S. cerevisiae and its sensu stricto relatives to diver-
gent yeast species (e.g.,Debaromyces hansenii and Yarro-
wia lipolytica) to filamentous fungi (e.g., Aspergillus
nidulans and Neurospora crassa) (see https://portals.
broadinstitute.org/cgi-bin/regev/orthogroups/show_
orthogroup.cgi?orf=YMR068W)—but is not conserved in
multicellular organisms that lack a cell wall. In this
same regard, genetic evidence indicates that the Slt2
ortholog (Pmk1) in fission yeast (Schizosaccharomyces
pombe) has a role in negatively regulating TORC2-medi-
ated activation of the fission yeast Ypk1 ortholog (Gad8)
(Cohen et al. 2014), providing further support for conser-
vation of the overall mechanism that we describe here.
Our results show that Avo2 is not only an important
site of Slt2-mediated phosphorylation but also necessary
for optimal TORC2 activity, especially under stressful
conditions. However, the function of Avo2 in TORC2 is
not currently known. Within its N-terminal half, Avo2
contains at least five ankyrin repeats (Gaubitz et al.
2016), which are known to mediate protein–protein inter-
actions but, in some cases, also interactions with other
classes of biomolecules. Initial dissection of the subunit
contacts in yeast TORC2 by coimmunoprecipitation
and pull-down assays suggested that Avo2 associates
only with Avo1 and Avo3 (Wullschleger et al. 2005). How-
ever, recent modeling of a predicted Avo2 structure into
the cryo-electron microscopy (cryo-EM) density of yeast
TORC2, if interpreted correctly, indicates intimate con-
tact of Avo2 with the HEAT repeat and FAT domain re-
gions of Tor2, much less extensive interaction with
Avo3, and no contact with Avo1 (Karuppasamy et al.
2017). Nonetheless, this placement is surface-exposed
and quite distant from the active site of the kinase domain
in Tor2 and hence does not readily suggest an obvious
function for Avo2 (Karuppasamy et al. 2017).
As first detected in global two-hybrid screens, Avo2 also
interacts with two other paralogous proteins, Slm1 and
Slm2, and the ability of Avo2 to associate with Slm1 and
Slm2 also has been observed by both coimmunoprecipita-
tion (Audhya et al. 2004) and in vitro binding assays (Fadri
et al. 2005). Slm1 and Slm2 are components of the furrow-
like PM invaginations called eisosomes that are coated
with the PtdIns4,5P2-binding F-BAR domain-containing
proteins Pil1 and Lsp1 (Karotki et al. 2011). Similarly,
the central ∼190 residues of Slm1 (686 residues) and
Slm2 (656 residues) contain a predicted I-BAR (inverse
BAR) domain (which is required for their targeting to eiso-
somes) (Olivera-Couto et al. 2011) and a demonstrated
∼110-residue PtdIns4,5P2-binding PH domain near their
C-terminal ends (Audhya et al. 2004; Gallego et al.
2010). Absence of Slm1 and Slm2 reportedly disrupts eiso-
some structure (Kamble et al. 2011).
It has been observed before that each component sub-
unit of TORC2 localizes around the cell periphery in
multiple PM-associated “dots” and that these puncta are
quite dynamic (Berchtold and Walther 2009), whereas
the eisosomes are considered rather static structures
(Brach et al. 2011). Moreover, it had been suggested that
these two compartments are discrete (Berchtold and Wal-
ther 2009). However, as we found and document here, a
substantial fraction of Avo2 is readily found in association
with the diagnostic eisosome marker Pil1, in agreement
with the observations of at least one other group (Bartlett
et al. 2015). Furthermore, there is convincing evidence
that the Avo2-interacting proteins and eisosome compo-
nents Slm1 and Slm2 are required for TORC2-mediated
phosphorylation of Ypk1 (Berchtold et al. 2012; Niles
et al. 2012). However, the model proposed was that, under
appropriate stress conditions (including hypotonic shock
and sphingolipid depletion), Slm1/2 dissociate from eiso-
somes, bind Ypk1, and deliver this substrate to the
TORC2 compartment (Berchtold et al. 2012; Niles et al.
2012). On the other hand, equally compelling data demon-
strate that it is the CRIM element present in Avo1 and its
orthologs in fission yeast (Sin1) and mammalian cells
(mSIN1) that binds and presents substrates to the catalytic
center in TORC2 (Liao and Chen 2012; Tatebe and Shio-
zaki 2017).
Hence, the findings that we describe here suggest an ob-
verse model; namely, that the role of Avo2 (assuming, as
its gene name indicates, that it “associates voraciously”
with Tor2 and the other components of TORC2) is to
act as an adaptor that, through its association with
Slm1/Slm2, is responsible for the dynamic docking of
TORC2 at eisosomes. What, then, is the function of the
Avo2–Slm1/2 interaction in promoting TORC2 function?
As demonstrated bymultiple groups (Bultynck et al. 2006;
Tabuchi et al. 2006), Slm1/2 also bind tightly Ca+2/cal-
modulin-activated phosphoprotein phosphatase 2B (also
known as calcineurin) and do so via canonical so-called
PxIxIT motifs located very near their C termini
(673PNIYIQ678 in Slm1 and 640PEFYIE645 in Slm2). Hence,
it is possible that the calcineurin bound to Slm1/2 acts to
remove the inhibitory phosphorylations present on Avo2
and other TORC2 subunits, thereby alleviating this nega-
tive regulation. Consistent with thismodel, we found that
Avo29E, an allele that mimics the permanently phosphor-
ylated state and hence would be immune to calcineurin
action, was inhibitory to optimal TORC2 function in
vivo, exhibited enhanced dissociation from PM sites,
and reduced association with TORC2. Thus, based on
the behavior of this phosphomimetic allele, a primary
Slt2 phosphorylates and down-regulates TORC2
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effect of Slt2-mediated phosphorylation is to impede its
integration into TORC2 and interfere with Avo2-mediat-
ed association of TORC2 with the cell cortex. Whether
Slt2 phosphorylation of Avo3 (or other TORC2 subunits)
further promotes this dissociation and other ramifications
of this model provide fertile ground for further study.
Finally, what we reveal here is one molecular mecha-
nism by which a stress signal restrains a growth-pro-
moting signal. As we document here for yeast, it seems
likely that MAPK pathways activated by stress will im-
pede TORC2 function in mammalian cells in a similar
manner because continued growth and response to stress
are invariably incompatible cellular states.
Materials and methods
Construction of yeast strains and growth conditions
Unless indicated otherwise in Table 1, S. cerevisiae strains used
in this work were all constructed using conventional yeast genet-
ic methods (Sherman 2002). Unless stated otherwise, yeast cul-
tures were grown in standard rich (YP) medium or defined
minimal (SC) medium (Sherman 2002) containing 2% glucose/
dextrose and were supplemented with the appropriate nutrients
to permit growth of auxotrophs and/or select for plasmids. Cul-
tures were propagated at 30°C, unless indicated otherwise. Induc-
tion of genes under the control ofGAL promoters was carried out
either by adding 2% galactose to strains pregrown in the appropri-
ate SC medium with 2% raffinose and 0.2% sucrose followed by
incubation over the course of 3 h or, for strains containing the
Gal4 human estrogen receptor herpes simplex virus transactiva-
tor VP16 fusion protein (Gal4-ER-VP16 [GEV]) (Quintero et al.
2007), by addition of 20 µM β-estradiol (final concentration) fol-
lowed by incubation over the course of 3 h. For strains containing
a protein tagged with an AID, the cells were cultured in YPD or
the appropriate SC medium buffered with 50 mM potassium
phosphate (pH 6.2), and degradation was induced by addition of
a synthetic auxin (1-NAA) (Sigma-Aldrich) for the indicated
time periods.
Plasmids and recombinant DNA methods
Plasmids used in this work (Table 2) were constructed using stan-
dard procedures in Escherichia coli strain DH5α (Green and Sam-
brook 2012). All PCR reactions were performed with Phusion
high-fidelity DNA polymerase (New England Biolabs, Inc.).
Site-directed mutagenesis was performed by using the appropri-
ate mismatch oligonucleotide primers with the QuikChange
method (AgilentTechnologies, Inc.) according to themanufactur-
er’s instructions. The fidelity of all constructs was verified by nu-
cleotide sequence analysis.
Cell extract preparation and immunoblotting
Samples of exponentially-growing cells were harvested by brief
centrifugation and stored at −80°C. Cell pellets were thawed on
ice and lysed in 150 µL of 1.85 M NaOH and 7.4% β-mercaptoe-
thanol. Proteins were precipitated by the addition of 150 µL of
50% trichloroacetic acid for 10 min on ice. Precipitated proteins
were pelleted by centrifugation and washed twice with ice-cold
acetone. Protein pellets were solubilized in 5% SDS in 0.1 M
Tris base, adjusted to a final concentration of 0.025 A600 nm per
microliter, mixed with one-fifth volume of 5× SDS sample buffer,
boiled for 10 min, and then resolved by SDS-PAGE. Phospho-
proteins were resolved by Phos-tag SDS-PAGE (Kinoshita et al.
2009): Phosphorylated Ypk1-myc was resolved in 8% acrylamide
gels containing 35 µMPhos-tag affinity reagent (WakoChemicals
USA, Inc.) and 70 µM MnCl2, phosphorylated Avo2-3xFlag was
resolved by in 8% acrylamide gels containing 17.5 µM Phos-tag
reagent and 35 µM MnCl2, and phosphorylated Avo3-3xFlag
was resolved in 8% acrylamide gels containing 20 µM Phos-tag
reagent and 40 µM MnCl2.
For immunoblotting, proteins in gels were transferred electro-
phoretically to a nitrocellulose membrane, incubated with Odys-
sey blocking buffer (Li-Cor Biosciences, Inc.) diluted 1:1 with PBS
or TBS, and then probed by addition of the appropriate primary
antibody at the indicated dilution: mouse anti-myc mAb 9E10
(1:100;Monoclonal Antibody Facility, Cancer Research Laborato-
ry, University of California at Berkeley), mouse anti-Flag
M2 mAb (1:10,000; Sigma-Aldrich), mouse anti-HA.11 mAb
(1:1000; BioLegend), rabbit polyclonal anti-RFP (1:5000; Rockland
Immunochemicals), rabbit polyclonal anti-tRFP (1:1000 to detect
mKate; Evrogen), or rabbit polyclonal anti-Pgk1 (1:30,000; this
laboratory, prepared as described in Baum et al. 1978). Activated
(dually phosphorylated) Hog1 was detected using rabbit anti-p38
MAPK phospho-Thr180/phospho-Tyr182 mAb (1:1000; Cell
Signaling Technology), and activated (dually phosphorylated)
Slt2 was detected using rabbit anti-p44/42 (Erk1/2) MAPK phos-
pho-Thr202/phospho-Tyr204 mAb (1:1000; Cell Signaling Tech-
nology). After rinsing the membranes, filter-bound immune
complexeswere detectedwith an appropriate infrared dye-labeled
secondary antibody—CF770-conjugated goat anti-mouse IgG
(Biotium), IRDye800CW-conjugated goat anti-rabbit IgG (Li-
Cor), or IRDye680RD-conjugated goat anti-mouse IgG (Li-Cor)
—that was diluted 1:10,000 in 1:1 Odyssey blocking buffer::PBS
(or TBS) containing 0.1% Tween-20 and 0.02% SDS and visual-
ized using an infrared imaging system (Odyssey CLx, Li-Cor).
Slt2 in vitro kinase assay
To purify activated Slt2, 1 L each of yeast strain CGA84 cotrans-
formed with PGAL1-PKC1∗ and either pKL63 (PGAL1-Slt2WT-TAP)
or pKL64 (PGAL1-Slt2KD-TAP) was grown to mid-exponential
phase at 30°C. Expression was induced by addition of 20 µM β-
estradiol followed by incubation for 3 h. The cells were harvested,
washed once in ice-cold TAP-B buffer containing phosphatase
and protease inhibitors (200 mM NaCl, 1.5 mM MgOAc, 1 mM
DTT, 2 mM NaVO4, 10 mM NaF, 10 mM Na-PPi, 10 mM β-
glycerol phosphate, 1× complete protease inhibitor [Roche],
50mMTris-HCl at pH 7.5), resuspended in 4mL of TAP-B buffer,
and flash-frozen as droplets in liquid N2. The cells were ruptured
cryogenically in a Mixer Mill MM301 (Retsch). The resulting ly-
sate was thawed on ice, diluted with 8 mL of TAP-B buffer, and
clarified by centrifugation at 15,000g for 20 min. The resulting
clarified extract was subjected to centrifugation at 78,000g for 1
h, and the resulting supernatant fraction was adjusted to a final
concentration of 0.15% NP-40 using an appropriate volume of a
10% NP-40 stock. Slt2-TAP in the detergent-containing soluble
fractionwas captured by binding to IgG-agarose resin (GEHealth-
care). After washing the resin extensively with TAP wash buffer
(200 mM NaCl, 1.5 mM MgOAc, 1 mM DTT, 0.01% NP-40,
2 mM NaVO4, 10 mM NaF, 10 mM Na-PPi, 10 mM β-glycerol
phosphate, 50mMTris-HCl at pH 7.5), it was washed with Prote-
ase 3Cbuffer (200mMNaCl, 1.5mMMgOAc, 1mMDTT, 0.01%
NP-40, 10% glycerol, 2mMNaVO4, 10mMNaF, 10mMNa-PPi,
10mM β-glycerol phosphate, 50mMTris-HCl at pH7.5). To elute
the bound Slt2-TAP, the washed resin was resuspended in 500 µL
of Protease 3C buffer containing 60 U of PreScission protease
(GE Healthcare). After incubation for 5 h at 4°C, the resin was
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removed by centrifugation, and the Protease 3C in the resulting
supernatant faction was removed by incubation with a slurry of
glutathione-Sepharose beads (GE Healthcare) followed by centri-
fugation. The affinity-purified Slt2 in the resulting final superna-
tant solution was diluted into kinase assay buffer (125 mM
potassium acetate, 5% glycerol, 12 mM MgCl2, 0.5 mM EGTA,
Table 1. S. cerevisiae strains used in this study
Strain Genotype Source or reference
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 Research Genetics,
Inc.
BY4742 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Research Genetics,
Inc.
JTY5336 BY4741 trp1::URA3 This study
YFR549 BY4741 slt2Δ::KanMX trp1::URA3 This study
YFR538-A BY4742 hog1Δ::KanMX trp1::URA3 This study
YFR560 BY4741 kss1Δ::CgHIS3 trp1::URA3 This study
YFR559 BY4741 slt2Δ::KanMX hog1Δ::KanMX trp1::URA3 This study
YFR567 BY4742 slt2Δ::KanMX kss1Δ::CgHIS3 trp1::URA3 This study
YFR564 BY4741 hog1Δ::KanMX kss1Δ::CgHIS3 trp1::URA3 This study
YFR617 BY4741 Avo3-3xFlag::KanMX trp1::URA3 This study
JTY5473 BY4741 sln1ts-4::KanMX Costanzo et al.
2010
yKL15 BY4741 Sln1-6xHA::HygR TIR1::HIS3 This study
yKL18 BY4741 Sln1-AID∗-6xHA::HygR TIR1::HIS3 This study
yKL20 BY4741 lys2Δ0 Sln1-AID∗-6xHA::HygR hog1Δ::KanMX TIR1::HIS3 This study
yKL16 BY4741 Sln1-AID∗-6xHA slt2Δ::URA3 TIR1::HIS3 This study
yKL22 BY4741 Sln1-AID∗-6xHA hog1Δ::KanMX slt2Δ::URA3 TIR1::HIS3 MET15 This study
JTY7318 BY4742 avo2Δ::KanMX Research Genetics,
Inc.
yKL32 BY4742 Avo2-3xFlag::URA3 This study
YFR181 BY4742 Pil1-RFP LYS2 met15Δ0 This study
YFR528 BY4742 Avo2(T144A T219A S233A S240A S249A T310A S315A T330A S333A)::URA3 This study
yKL31 BY4742 Avo2(T144E T219E S233E S240E S249E T310E S315E T330E S333E)::URA3 This study
yKL33 BY4742 Avo2(T144A T219A S233A S240A S249A T310A S315A T330A S333A)-3xFlag::URA3 This study
yKL34 BY4742 Avo2(T144E T219E S233E S240E S249E T310E S315E T330E S333E)-3xFlag::URA3 This study
yEPS2 BY4741 Pil1(S163D S230D T233D::URA3 This study
YFR641 BY4741 Avo2(T144E T219E S233E S240E S249E T310E S315E T330E S333E)::URA3 Pil1(S163D
S230D T233D::URA3
This study
yAEA348 BY4741 Pil1-RFP Avo2-mNG-3xHA::URA3 This study
yAEA349 BY4741 Pil1-RFP Avo2(T144A T219A S233A S240A S249A T310A S315A T330A S333A)-mNG-
3xHA::URA3
This study
yAEA350 BY4741 Pil1-RFP Avo2(T144E T219E S233E S240E S249E T310E S315E T330E S333E)-mNG-
3xHA::URA3
This study
yAEA301-
Aa
BY4742 Tor2-mNG-3xHA This study
YFR589 BY4741 Avo2-mKate::SpHIS5 Tor2-mNG-3xHA This study
YFR624 BY4741 Avo2-mKate::SpHIS5 Tor2-mNG-3xHA Avo3-3xFlag::KanMX This study
YFR626 BY4741 Avo2(T144A T219A S233A S240A S249A T310A S315A T330A S333A)-mKate::SpHIS5
Tor2-mNG-3xHA Avo3-3xFlag::KanMX
This study
YFR628 BY4741 Avo2(T144E T219E S233E S240E S249E T310E S315E T330E S333E)-mKate::SpHIS5
Tor2-mNG-3xHA Avo3-3xFlag::KanMX
This study
CGA84 MATa leu2Δ1::GEV::NATMX pep4Δ::HIS3 prb1Δ1.6R ura3-52 trp1-1 lys2-801a leu2Δ1 his3Δ200
can1 GAL
Alvaro et al. 2014
aFor strain yAEA301-A, the coding sequence for an mNG-3xHA cassette was inserted in-frame between Asn321 and Thr322 of the
TOR2 ORF on chromosome XI, constructed using a CRISPR–Cas9-based method. In brief, BY4742 was transformed with URA3-
marked pRS316-GALprom-Cas9 (pGF-V789) (Finnigan and Thorner 2016), expression of Cas9 was induced in a resulting transformant by
addition of galactose (2% final concentration), and, after 6 h, the cells were cotransformed with HIS3-marked pRS423-sgRNA-Tor2
(pAEA272) and a TOR2-mNG-3xHA-TOR2 repair cassette generated and amplified by overlap extension PCR using appropriate DNA
templates and synthetic oligonucleotide primers. The desired (viable) transformants were selected on SCD − Ura −His plates and then
colony-purified by streaking on SD + Ura + His plates containing 5-FOA (to select for derivatives that lost pGF-V789 and pAEA272). The
single-guide RNA (sgRNA) encoded by pRS423-sgRNA-Tor2 (pAEA272) was −463ATTTTGGCGCCAGTGA TAAGTGG−441 (the PAM
sequence is underlined) directed against the corresponding sequence within the TOR2 promoter (where +1 is the first base of the initia-
tor ATG of the TOR2 ORF). In the upstream primer used to generate the TOR2-mNG-3xHA-TOR2 repair cassette DNA, to prevent rec-
ognition by the sgRNA, the sequence in and around the PAM was mutated to −446TAGTCG−441. The proper in-frame insertion of the
mNG-3xHA-coding sequence in the TOR2 ORF was verified by colony PCR and DNA sequencing.
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2 mM DTT, 1 mM PMSF, 0.1 mM chymostatin, 4 mM AEBSF,
12.5 mM β-glycerol phosphate, 1 mM NaVO4, 40 mM Tris-HCl
at pH 7.5).
Substrates to be tested were purified as recombinant proteins
by fusion to the C terminus of GST in appropriate pGEX vectors
and expressed inE. coliBL21(DE3)pLysS.One liter of cultureswas
grown at 30°C to mid-exponential phase and then induced with
0.5 mM IPTG for 3 h at 30°C. The bacterial cells were harvested
by centrifugation and lysed, and the GST fusion protein of inter-
est was adsorbed to glutathione-agarose beads (Prometheus Labo-
ratories Inc.), whichwerewashed and resuspended in kinase assay
buffer. The same volume of either affinity-purified Slt2WT or
Slt2KD was added to the resuspended beads or an equivalent vol-
ume of kinase assay buffer, and reaction was initiated by the ad-
dition of 2 µCi of [γ-32P]ATP and unlabeled ATP to 100 µM
final concentration. After incubation for 30 min at 30°C, reac-
tions were terminated by addition of 5× SDS-PAGE sample buffer
followed by boiling for 10 min. The resulting reaction products
were resolved by SDS-PAGE and analyzed by Coomassie blue
staining and autoradiography using a phosphorimager (Typhoon,
GE Healthcare).
Immunoprecipitation of TORC2
One-hundred milliliters of cultures of yeast strains express-
ing Avo3-3xFlag Tor2-mNG-3xHA and either Avo2-mKate
(YFR624), Avo29A-mKate (YFR626), or Avo29E-mKate (YFR628)
was grown in YPD tomid-exponential phase, harvested by centri-
fugation, and frozen in liquid nitrogen. Cells pellets were resus-
pended in 500 µL of 2× TNEG buffer (100 mM Tris at pH 7.6,
300 mM NaCl, 20% glycerol, 0.24% Tergitol, 2 mM EDTA,
0.1 mM PMSF, 1× Roche complete protease inhibitor tablet
[Roche]). Glass beads were added to the meniscus of the cell sus-
pension, and lysis was achieved by vigorous vortex mixing for 3
min. After lysis, 2× vol of 1× TNEG buffer was added, and then
the lysate was clarified by centrifugation at 1000g for 5 min at
4°C followed by a second centrifugation at 2000g for 10 min.
TORC2 complexes marked by the tightly bound Avo3-3xFlag
subunit were collected by immunoabsorption to 40 µL of mouse
anti-Flag affinity gel (Biotool) equilibrated in 1× TNEG buffer.
The resin was washed four times with 1 mL of 1× TNEG buffer
and resuspended in 2× urea buffer.
Fluorescence microscopy and image analysis
Fluorescence microscopy was performed using an Elyra PS.1
structured illumination microscope (Carl Zeiss AG) equipped
with a 100× plan-apo 1.46NA TIRF objective, a main focus drive
of the AxioObserver Z1 stand, and a WSB PiezoDrive 08 con-
trolled by Zen, and images were recorded using a 512×512
(100-nm×100-nm pixel size) EM-CCD camera (Andor Technolo-
gy). To visualize Avo2 or Tor2 tagged with mNG (excitation λmax
506 nm; emission λmax 517), cell samples were excited with an
argon laser at 488 nm at 2.3% power (100 mW), and emission
was captured in a 495- to 550-nmwindow using a bandpass filter;
for Pil1 tagged with RFP/DsRed (excitation λmax 558 nm; emis-
sion λmax 583), excitation was at 561 nm at 2.3% power (100
mW), and emission was monitored in a 570- to 620-nm window
using a different bandpass filter. Images (average of eight scans;
300 msec/scan) were analyzed using Fiji (Schindelin et al.
2012). To avoid changes in image quality due to occasional fluc-
tuations in laser intensity, all panels shown in any given figure
represent experiments performed on the same day and scaled
and adjusted identically for brightness using Fiji (Schindelin
et al. 2012). For quantitative automated analysis of fluorescence
intensity at the PM, CellProfiler was used (Carpenter et al.
2006). To train CellProfiler to apply the appropriate mask and
quantify the signal, a corresponding pipeline was created, which
was adapted from prior software (Bray et al. 2015; Chong et al.
2015). Prior to loading into the CellProfiler pipeline, cell images
were segmented manually using Fiji (Schindelin et al. 2012). To
avoid any selection bias, every cell visible in the bright-field im-
age in a frame from any sample (except those out of focus) was
chosen. All plots and statistical analyses in this study were
performed with the R statistical analysis package (http://www.
R-project.org).
Table 2. Plasmids used in this study
Plasmid Description Source or reference
pRS315 CEN, LEU2, vector Sikorski and Hieter
1989
pFR246 pRS315 Ypk1(T51A T71A T504A S644A T662A)-myc Leskoske et al. 2017
pKL1 pRS315 Avo2-3xFlag This study
pKL2 pRS315 Avo2(T144A T219A S233A S240A S249A T310A S315A T330A S333A)-
3xFlag
This study
pFR234 pRS315 Ypk1(D242A)-myc Roelants et al. 2017b
yEPlac112 2 µm, TRP1, vector Gietz and Sugino 1988
Pkc1∗ (pJT5660) YEplac112 PGAL1-Pkc1(R398A R405A R406A) Martín et al. 2000
pJEN12
(Pkc1∗KD)
YEplac112 PGAL1-Pkc1(R398A R405A R406A D949A) This study
pAEA376 YEplac112 PGAL1-Pkc1(R398A R405A R406A)-myc This study
pJEN13 YEplac112 PGAL1-Pkc1(R398A R405A R406A D949A)-myc This study
BG1805 2 µm, URA3, PGAL1, C-terminal tandem affinity (TAP) tag vector Open Biosystems, Inc.
pKL63 BG1805 Slt2 This study
pKL64 BG1805 Slt2(K54R) This study
pGEX6P-1 GST tag, bacterial expression vector GE Healthcare, Inc.
pKL16 pGEX6P-1 Avo2 This study
pKL17 pGEX6P-1 Avo2(T144A T219A S233A S240A S249A T310A S315A T330A S333A) This study
pKL81 pGEX6P-1 Avo3(1-100) This study
pKL82 pGEX6P-1 Avo3(1-100)(S11A T24A T28A S50A S84A S87A) This study
Leskoske et al.
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SUPPLEMENTAL FIGURES 
 
 
 
Fig. S1. TORC2 function is not affected by phospho-mimetic Pil1 allele. Wild-type (BY4742) 
or Pil13D (yEPS2) strains were cultured to mid-exponential phase in selective minimal medium 
and then treated with vehicle (methanol) or 1.25 µM myriocin for 2 h. After harvesting, whole-cell 
lysates were prepared, resolved by SDS-PAGE, and analyzed as described in Materials and 
Methods. 
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Fig. S2. TORC2 function is down-regulated after Sln1 inactivation.  (A) Wild-type cells 
(BY4741) and an otherwise isogenic sln1ts derivative (JTY5473) expressing Ypk15A-myc from its 
native promoter on a CEN plasmid (pFR246) were propagated at 26˚C to mid-exponential 
phase and then a portion of the culture was maintained at 26˚C and another portion shifted to 
37˚C. After 2 h at the respective temperatures, samples of the separate cultures were 
harvested, lysed and Ypk1 phosphorylation analyzed by Phos-tag SDS-PAGE and 
immunoblotting. Pgk1 was the loading control. (B) Strain JTY5473 (sln1ts) expressing either 
Avo2-3xFLAG (pKL1) or Avo29A-3xFLAG (pKL2) were grown to mid-exponential phase and then 
either kept at 26˚C or shifted to 37˚C. After 2 h, Avo2 phosphorylation was analyzed as in (A).   
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Fig. S3. Challenge with a high exogenous sorbitol concentration rapidly diminished 
TORC2-mediated Ypk1 phosphorylation. Strains JTY5336 (HOG1+ SLT2+), YFR549 (slt2∆), 
YFR538A (hog1∆), and YFR559 (slt2∆ hog1∆), each expressing Ypk15A-myc from its native 
promoter on a CEN plasmid (pFR246), were grown to mid-exponential phase, then diluted into 
fresh SCD-Leu medium in the absence (-) or presence (+) of sorbitol (1 M final concentration). 
After 5 min, the cells were harvested, lysed and the resulting extracts subjected to Phos-tag 
SDS-PAGE to resolve Ypk1 phosphorylation and to standard SDS-PAGE to resolve the other 
proteins, and analyzed by immunoblotting, as described in Materials and Methods.  
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Fig. S4. Avo2-mNG-3xHA is fully biologically functional. Overnight cultures of otherwise 
isogenic Pil1-RFP (yFR181) and Pil1-RFP Avo2-mNG-3xHA (yAEA348) strains were adjusted 
to A600nm = 0.1, spotted undiluted and in a series of 10-fold serial dilutions on YPD plates either 
lacking or containing myriocin at the indicated concentrations, incubated at 30°C for 3 d, and 
then imaged. 
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Fig. S5. Illustration of the masking used to quantify fluorescent images of the cell 
periphery with CellProfiler. The images and other data shown in Fig. 5 were obtained using a 
custom CellProfiler pipeline, as described in Materials and Methods. The blob-like or thread-like 
cytosolic structures observed in the GFP channel are due to intrinsic autofluorescence of the 
mitochondria.  
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Fig. S6. The state of Avo2 phosphorylation does not affect Tor2 localization.  (A) Strains 
YFR624 (Avo2-mKate Tor2-mNG-3xHA Avo3-3xFLAG), YFR626 (Avo29A-mKate Tor2-mNG-
3xHA Avo3-3xFLAG) and YFR628 (Avo29E-mKate Tor2-mNG-3xHA Avo3-3xFLAG) were grown 
to mid-exponential phase and examined by fluorescence microscopy as described in Materials 
and Methods and processed using CellProfiler (as in Fig. S3). (B) Mean values of the relative 
pixel intensities of the Tor2-mNG foci in images, as in (A), were measured using CellProfiler, 
and those obtained for strain YFR624 (Avo2-mKate Tor2-mNG-3xHA Avo3-3xFLAG) were set 
to 100%, to which all the other values were normalized. Error bars represent 95% confidence 
intervals. 
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